| [1] |
Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation[J]. Sci Transl Med, 2014, 6(265): 265sr6.
|
| [2] |
Julie K, Nguyen, et al. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets[J]. Arch Dermatol Res, 2020, 312(2): 81-92.
|
| [3] |
Salmon-Ehr V, Ramont L, Godeau G, et al. Implication of interleukin-4 in wound healing[J]. Lab Invest, 2000, 80(8)：1337-1343.
|
| [4] |
Xiao S, Huang G, Wei Z, et al. IL-10 gene-modified human amniotic mesenchymal stem cells augment regenerative wound healing by multiple synergistic effects[J]. Stem Cells Int, 2019, 2019: 9158016.
|
| [5] |
Wang Y, Bai Y, Li Y, et al. IL-15 enhances activation and IGF-1 production of dendritic epidermal T cells to promote wound healing in diabetic mice[J]. Front Immunol, 2017, 24(8): 1557.
|
| [6] |
Lee J, Rodero MP, Patel J, et al. Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization[J]. FASEB J, 2018, 32(4): 2086-2094.
|
| [7] |
Groves RW, Schmidt-Lucke JA. Recombinant human GM-CSF in the treatment of poorly healing wounds[J]. Adv Skin Wound Care, 2000, 13(3): 107-112.
|
| [8] |
Rho CR, Park MY, Kang S. Effects of granulocyte-macrophage colony-stimulating (GM-CSF) factor on corneal epithelial cells in corneal wound healing model[J]. PLoS One, 2015, 10(9): e0138020.
|
| [9] |
Mann A, Breuhahn K, Schirmacher P, et al. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization[J]. J Invest Dermatol, 2001, 117(6): 1382-1390.
|
| [10] |
Mann A, Niekisch K, Schirmacher P, et al. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing[J]. J Investig Dermatol Symp Proc, 2006, 11(1): 87-92.
|
| [11] |
Fang Y, Gong SJ, Xu YH, et al. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice[J]. Br J Dermatol, 2007, 157(3): 458-465.
|
| [12] |
Fang Y, Shen J, Yao M, et al. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines[J]. Br J Dermatol, 2010, 162(3): 478-486.
|
| [13] |
Castro-Dopico T, Fleming A, Dennison TW, et al. GM-CSF calibrates macrophage defense and wound healing programs during intestinal infection and inflammation[J]. Cell Rep, 2020, 32(1): 107857.
|
| [14] |
Hu X, Sun H, Han C, et al. Topically applied rhGM-CSF for the wound healing: a systematic review[J]. Burns, 2011, 37(5): 729-741.
|
| [15] |
Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2014, 22(5): 569-578.
|
| [16] |
Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells[J]. Am J Pathol, 2004, 164(6): 1935-1947.
|
| [17] |
Gopalakrishnan A, Ram M, Kumawat S, et al. Quercetin accelerated cutaneous wound healing in rats by increasing levels of VEGF and TGF-β1[J]. Indian J Exp Biol, 2016, 54(3): 187-195.
|
| [18] |
Zhou J, Ni M, Liu X, et al. Curcumol promotes vascular endothelial growth factor (VEGF)-mediated diabetic wound healing in streptozotocin-induced hyperglycemic rats[J]. Med Sci Monit, 2017, 23: 555-562.
|
| [19] |
Liu C, Hao Y, Huang J, et al. Ghrelin accelerates wound healing in combined radiation and wound injury in mice[J]. Exp Dermatol, 2017, 26(2): 186-193.
|
| [20] |
Boyar V. Association of systemic or intravitreal antivascular endothelial growth factor (Anti-VEGF) and impaired wound healing in pediatric patients: collagen to the rescue[J]. J Wound Ostomy Continence Nurs, 2021, 48(3): 256-261.
|
| [21] |
Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis[J]. J Exp Med, 2002, 196(11): 1497-1506.
|
| [22] |
Hirakawa S, Kodama S, Kunstfeld R, et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis[J]. J Exp Med, 2005, 201(7): 1089-1099.
|
| [23] |
Koike Y, Yozaki M, Utani A, et al. Fibroblast growth factor 2 accelerates the epithelial-mesenchymal transition in keratinocytes during wound healing process[J]. Sci Rep, 2020, 10(1): 18545.
|
| [24] |
Kinoda J, Ishihara M, Nakamura S, et al. Protective effect of FGF-2 and low-molecular-weight heparin/protamine nanoparticles on radiation-induced healing-impaired wound repair in rats[J]. J Radiat Res, 2018, 59(1): 27-34.
|
| [25] |
Andres C, Hasenauer J, Ahn HS, et al. Wound-healing growth factor, basic FGF, induces Erk1/2-dependent mechanical hyperalgesia[J]. Pain, 2013, 154(10): 2216-2226.
|
| [26] |
Wu J, Zhu J, He C, et al. Comparative study of heparin-poloxamer hydrogel modified bFGF and aFGF for in vivo wound healing efficiency[J]. ACS Appl Mater Interfaces, 2016, 8(29): 18710-18721.
|
| [27] |
Peng Y, Wu S, Tang Q, et al. KGF-1 accelerates wound contraction through the TGF-beta1/Smad signaling pathway in a double-paracrine manner[J]. J Biol Chem, 2019, 294(21): 8361-8370.
|
| [28] |
Xiaojie W, Banda J, Qi H, et al. Scarless wound healing: current insights from the perspectives of TGF-β，KGF-1, and KGF-2[J]. Cytokine Growth Factor Rev, 2022, 66: 26-37.
|
| [29] |
Watson J, Francavilla C. Regulation of FGF10 signaling in development and disease[J]. Front Genet, 2018, 9: 500.
|
| [30] |
Xu K, Chai B, Zhang K, et al. Topical application of fibroblast growth factor 10-PLGA microsphere accelerates wound healing via inhibition of ER stress[J]. Oxid Med Cell Longev, 2020, 2020: 8586314.
|
| [31] |
Oh JS, Lee EJ. Engineered dressing of hybrid chitosan-silica for effective delivery of keratin growth factor and acceleration of wound healing[J]. Mater Sci Eng C Mater Biol Appl, 2019, 103: 109815.
|
| [32] |
Bienert M, Hoss M, Bartneck M, et al. Growth factor-functionalized silk membranes support wound healing in vitro[J]. Biomed Mater, 2017, 12(4): 045023.
|
| [33] |
Pan H, Shi C, Yang R, et al. Controlled release of KGF-2 for regulation of wound healing by KGF-2 complexed with "lotus seedpod surface-like" porous microspheres[J]. J Mater Chem B, 2021, 9(19): 4039-4049.
|
| [34] |
Kaltalioglu K, Coskun-Cevher S. A bioactive molecule in a complex wound healing process: platelet-derived growth factor[J]. Int J Dermatol, 2015, 54(8): 972-977.
|
| [35] |
Wu LW, Chen WL, Huang SM, et al. Platelet-derived growth factor-AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing [J]. FASEB J, 2019, 33(2): 2388-2395.
|
| [36] |
Shi R, Lian W, Han S, et al. Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats[J]. Gene Ther, 2018, 25(6): 425-438.
|
| [37] |
Di Santo MC, Alaimo A, Acebedo SL, et al. Biological responses induced by high molecular weight chitosan administrated jointly with platelet-derived growth factors in different mammalian cell lines [J]. Int J Biol Macromol, 2020, 158: 953-967.
|
| [38] |
Mulder G, Tallis AJ, Marshall VT, et al. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial[J]. Wound Repair Regen, 2009, 17(6): 772-779.
|
| [39] |
Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5): 585-601.
|
| [40] |
Choi SM, Lee KM, Kim HJ, et al. Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice[J]. Acta Biomater, 2018, 66: 325-334.
|
| [41] |
Yoon D, Yoon D, Cha HJ, et al. Enhancement of wound healing efficiency mediated by artificial dermis functionalized with EGF or NRG1[J]. Biomed Mater, 2018, 13(4): 045007.
|
| [42] |
Qiang W, Zhou T, Lan X, et al. A new nanoscale transdermal drug delivery system: oil body-linked oleosin-hEGF improves skin regeneration to accelerate wound healing[J]. J Nanobiotechnology, 2018, 16(1): 62.
|
| [43] |
Dao DT, Anez-Bustillos L, Adam RM, et al. Heparin-binding epidermal growth factor-like growth factor as a critical mediator of tissue repair and regeneration[J]. Am J Pathol, 2018, 188(11): 2446-2456.
|
| [44] |
Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-β family in wound healing, burns and scarring: a review[J]. Int J Burns Trauma, 2012, 2(1): 18-28.
|
| [45] |
Le M, Naridze R, Morrison J, et al. Transforming growth factor Beta 3 is required for excisional wound repair in vivo[J]. PLoS One, 2012, 7(10): e48040.
|
| [46] |
Occleston NL, OKane S, Laverty HG, et al. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring[J]. Wound Repair Regen, 2011, 19(1): s38-s48.
|
| [47] |
Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGFβ1/Smad3 signalling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction[J]. J Clin Invest, 2003, 112(10)：1486-1494.
|
| [48] |
Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review[J]. Rev Endocr Metab Disord, 2019, 20(2)：207-217.
|
| [49] |
Martino MM, Briquez PS, Guc E, et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing[J]. Science, 2014, 343(6173): 885-888.
|
| [50] |
White MJV, Briquez PS, White DAV, et al. VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes[J]. NPJ Regen Med, 2021, 6(1): 76.
|
| [51] |
韩春茂，程飚．皮肤创面外用生长因子的临床指南[J]．中华烧伤杂志，2017, 33(12): 721-727.
|